SHARE: +/-: 0.05 SEK / Bid: 10.25 SEK / Ask: 10.65 SEK / Price: 10.70 SEK / High: 10.70 SEK / Low: 10.65 SEK / Quantity: 500 / Turnover: 5 330 SEK / 2019-04-18 10:36 (CEST)
 

Business Development

Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.

We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.

For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se